In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei

Clinical and Vaccine Immunology

Volumn 18, Issue 5, 2011, Pages 825-834

  Zhang, Shimin ^a   Feng, Shaw Huey ^a   Li, Bingjie ^a,b   Kim, Hyung Yong ^a   Rodriguez, Joe ^a   Tsai, Shien ^a   Lo, Shyh Ching ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBODY DETECTION; ANTIGEN BINDING; ANTIGEN PURIFICATION; ARTICLE; BACTERIAL GROWTH; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LD 50; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; FEMALE; GLANDERS; IMMUNOLOGIC FACTORS; MELIOIDOSIS; MICE; MICE, INBRED BALB C; MICROBIAL VIABILITY; PHAGOCYTOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79955726034     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00533-10     Document Type: Article

References (30)

1. Barnes, J. L., and N. Ketheesan. 2007. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens. Immunol. Cell Biol. 85:551-557.
2. Bondi, S. K., and J. B. Goldberg. 2008. Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei. Expert Rev. Vaccines 7:1357-1365.
3. Cheng, A. C., and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
4. Collins, S. J., R. C. Gallo, and R. E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347-349.
5. Collins, S. J., F. W. Ruscetti, R. E. Gallagher, and R. C. Gallo. 1978. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. U. S. A. 75:2458-2462.
6. Deris, Z. Z., H. Hasan, and M. N. Siti Suraiya. Clinical characteristics and outcomes of bacteraemic melioidosis in a teaching hospital in a northeastern state of Malaysia: a five-year review. J. Infect. Dev. Ctries. 4:430-435.
7. DeShazer, D., et al. 2000. Laboratory-acquired human glanders - Maryland, May 2000. MMWR Morb. Mortal. Wkly. Rep. 49:532-535.
8. Elvin, S. J., et al. 2006. Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization. Infect. Immun. 74:1706-1711.
9. Feng, S. H., et al. 2006. Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei. Hybridoma (Larchmt.) 25:193-201.
10. Fleck, R. A., S. Romero-Steiner, and M. H. Nahm. 2005. Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies. Clin. Diagn. Lab. Immunol. 12:19-27.
11. Frangoulidis, D., et al. 2008. 'Imported' melioidosis in Germany: relapse after 10 years. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1):S40-S41.
12. Gilad, J., I. Harary, T. Dushnitsky, D. Schwartz, and Y. Amsalem. 2007. Burkholderia mallei and Burkholderia pseudomallei as bioterrorism agents: national aspects of emergency preparedness. Isr. Med. Assoc. J. 9:499-503.
13. Ho, M., et al. 1997. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect. Immun. 65:3648-3653.
14. Ismail, G., N. Razak, R. Mohamed, N. Embi, and O. Omar. 1988. Resistance of Pseudomonas pseudomallei to normal human serum bactericidal action. Microbiol. Immunol. 32:645-652.
15. Jones, S. M., J. F. Ellis, P. Russell, K. F. Griffin, and P. C. Oyston. 2002. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J. Med. Microbiol. 51:1055-1062.
16. Leelarasamee, A. 1998. Burkholderia pseudomallei: the unbeatable foe? Southeast Asian J. Trop. Med. Public Health 29:410-415.
17. Mackie, T. J., and M. H. Finkelstein. 1931. Natural bactericidal antibodies: observations on the bactericidal mechanism of normal serum. J. Hygiene 31:35-55.
18. Ota, A., and S. Ueda. 1998. Evaluation of the affinity measurement of anti-HIV-1 p17 monoclonal antibody by BIAcore. Hybridoma 17:471-477. (Pubitemid 28565811)
19. Peacock, S. J. 2006. Melioidosis. Curr. Opin. Infect. Dis. 19:421-428.
20. Reed, L. J., and H. A. Muench. 1938. Simple method of estimating fifty percent endpoints. Am. J. Hyg. (Lond.) 27:493-497.
21. Ricketts, H. T. 1906. Infection, immunity and serum therapy. American Medical Association Press, Washington, DC.
22. Romero-Steiner, S., et al. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
23. Tarella, C., D. Ferrero, E. Gallo, G. L. Pagliardi, and F. W. Ruscetti. 1982. Induction of differentiation of HL-60 cells by dimethyl sulfoxide: evidence for a stochastic model not linked to the cell division cycle. Cancer Res. 42:445-449.
24. Trevino, S. R., et al. 2006. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge. Infect. Immun. 74:1958-1961.
25. Valvano, M. A., K. E. Keith, and S. T. Cardona. 2005. Survival and persistence of opportunistic Burkholderia species in host cells. Curr. Opin. Microbiol. 8:99-105.
26. Whitlock, G. C., D. M. Estes, and A. G. Torres. 2007. Glanders: off to the races with Burkholderia mallei. FEMS Microbiol. Lett. 277:115-122.
27. Wiersinga, W. J., T. van der Poll, N. J. White, N. P. Day, and S. J. Peacock. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4:272-282.
28. Zhou, Z. H., et al. 2007. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1:51-61.
29. Zou, N., et al. 2008. Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs. Hybridoma (Larchmt.) 27:231-240.
30. Zwietering, M. H., I. Jongenburger, F. M. Rombouts, and K. van 't Riet. 1990. Modeling of the bacterial growth curve. Appl. Environ. Microbiol. 56:1875-1881.